Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Web – sheet or filament bases; compositions of bandages; or...
Patent
1991-12-24
1993-07-06
Page, Thurman K.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Web, sheet or filament bases; compositions of bandages; or...
424448, 424449, 602 57, 602 58, 604304, 604307, A61F 1300
Patent
active
052251993
DESCRIPTION:
BRIEF SUMMARY
FIELD OF THE ART
The present invention relates to pharmaceutical plasters which can be used in treatment for a variety of diseases.
BACKGROUND OF THE ART
As the administration routes of medicines, ointments or the like have been frequently used as a local administration in addition to conventional ones such as oral, injection or rectal administrations. Further in recent years, the technical development has made steady progress in transdermal application of systemically acting drugs and several kinds of drugs have come to be clinically used in practice.
Since the transdermal administration of drugs enables them to avoid the first-pass effect which they would suffer in liver, if they were orally given, drug concentration in blood is far more stable than in the case of oral or injection administration, and many advantages also can be obtained, for example, longer effective time, easier removal of the drug by detaching the preparation in case of serious side-effects, and the like.
These merits have received strong attention and changes of conventional oral route preparations to transdermal ones have been investigated on a variety of drugs.
As clinical application of the transdermal preparations has made advance, however, the difficulties and problems in the transdermal route have become clear.
Several of them are as follows:
(1) One of the most serious problems of the transdermal preparations is outbreak of local irritation and skin rash or contact dermatitis. According to a statistics, the incidence of rash is 20 to 50% by transdermal preparations of a typical occlusive type tape.
In many cases, however, the patients must use such preparations for their merits, even when the application of such preparations results in rash development.
Further, many of the drugs used clinically today are generally resistant to transdermal absorption and, even in the drugs which are transdermally absorbable, the absorption of the clinically effective amount needs enlarged application areas and combination of additives such as an absorption-promoting agent.
The enlarged application areas and the use of absorption-promoting agent and the like frequently bring about increased areas and aggravation of skin rash.
Thus, a transdermally applicable preparation which enables the absorption of a clinically effective dose of the drug with skin rash eruption inhibited is desired.
(2) In addition, while a transdermal preparation is applied for a long time, the preparation is stained or becomes peelable with time, especially bathing accelerates the removability.
It is troublesome, however, to apply a new plaster, every time the old one peels off. Moreover, the dose control becomes difficult, satisfactory efficacy cannot be attained and problems remain in appearance and hygiene.
Thus, a transdermal preparation which is resistant to staining and peeling are desired even after prolonged application.
(3) By the way, a transdermal preparation is of a sustained release type and particularly effective for chronic diseases or diseases requiring long-term treatment. And the patients with such diseases are elder people of high age in many cases. Generally, however, elder people are not good at handling which requires complicated operation.
Thus, a transdermal preparation is desired to be easy to handle for the patients, in addition to pharmaceutic satisfactions such as high absorption and the like.
Conventionally, as a plaster aiming at absorption of a clinically effective amount of a drug with skin rash inhibited, for example, the plasters according to the present inventors are known, which bear a knitted fabric of microporous hollow fibers as a constituent (WO 87/00046, WO 87/04343 and WO 90/09784).
Such plasters have been satisfactory for skin rash reduction and absorption of a clinically effective amount of a drug, but other more excellent plasters which cause no skin rash and resist peeling, even when applied for a more prolonged time, thus revealing sufficient efficacy with no problem of appearance, have been still desired.
In other words,
REFERENCES:
patent: 3598123 (1971-08-01), Zaffaroni
patent: 4554317 (1985-11-01), Behar
patent: 4743499 (1988-05-01), Volke
patent: 4801458 (1989-01-01), Hidaka et al.
patent: 4906240 (1990-03-01), Reed
patent: 4915102 (1990-04-01), Kwiatek
patent: 4990340 (1991-02-01), Hidaka et al.
patent: 4997425 (1991-03-01), Shioya
patent: 5035893 (1991-07-01), Shioya
patent: 5045319 (1991-09-01), Chien
patent: 5064422 (1991-11-01), Wilk
Hidaka Osafumi
Murakami Satoshi
Page Thurman K.
Phelan D. Gabrielle
Teijin Limited
LandOfFree
Pharmaceutical plasters does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical plasters, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical plasters will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1688158